210 related articles for article (PubMed ID: 8080674)
21. Tropisetron in the prevention of acute and delayed nausea and vomiting over six courses of emetogenic chemotherapy.
Bleiberg H; Hulstaert F; Buyse M; De Keyser P
Anticancer Drugs; 1998 Oct; 9(9):773-7. PubMed ID: 9840722
[TBL] [Abstract][Full Text] [Related]
22. Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients.
Aass N; Håtun DE; Thoresen M; Fosså SD
Radiother Oncol; 1997 Nov; 45(2):125-8. PubMed ID: 9424001
[TBL] [Abstract][Full Text] [Related]
23. The development of tropisetron in its clinical perspective.
de Bruijn KM
Ann Oncol; 1993; 4 Suppl 3():19-23. PubMed ID: 8363994
[TBL] [Abstract][Full Text] [Related]
24. Prevention of chemotherapy-induced nausea and emesis in patients responding poorly to previous antiemetic therapy. Comparing tropisetron with optimised standard antiemetic therapy.
Bruntsch U; Drechsler S; Hiller E; Eiermann W; Tulusan AH; Bühner M; Hartenstein R; Koenig HJ; Gallmeier WM
Drugs; 1992; 43 Suppl 3():23-6. PubMed ID: 1380429
[TBL] [Abstract][Full Text] [Related]
25. Tropisetron in the prevention of nausea and vomiting in 131 children receiving cytotoxic chemotherapy.
Benoit Y; Hulstaert F; Vermylen C; Sariban E; Hoyoux C; Uyttebroeck A; Otten J; Laureys G; De Kerpel I; Nortier D
Med Pediatr Oncol; 1995 Dec; 25(6):457-62. PubMed ID: 7565308
[TBL] [Abstract][Full Text] [Related]
26. A randomized, double-blind, multicentre study comparing daily 2 and 5 mg of tropisetron for the control of nausea and vomiting induced by low-dose cisplatin- or non-cisplatin-containing chemotherapy.
Wymenga AN; van der Graaf WT; Wils JA; Siegenbeek van Heukelom L; van der Linden GH; Dullemond-Westland AC; Nooy M; van der Heul C; de Bruijn KM; de Vries EG
Ann Oncol; 1996 Jul; 7(5):505-10. PubMed ID: 8839906
[TBL] [Abstract][Full Text] [Related]
27. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M
Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907
[TBL] [Abstract][Full Text] [Related]
28. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting in patients responding poorly to previous conventional antiemetic therapy.
Bruntsch U; Rüfenacht E; Parker I; Drechsler S; de Bruijn K
Ann Oncol; 1993; 4 Suppl 3():25-9. PubMed ID: 8363995
[TBL] [Abstract][Full Text] [Related]
29. Tropisetron and metoclopramide in the prevention of postoperative nausea and vomiting. A comparative, placebo controlled study in patients undergoing ophthalmic surgery.
Ali-Melkkilä T; Kanto J; Katevuo R
Anaesthesia; 1996 Mar; 51(3):232-5. PubMed ID: 8712322
[TBL] [Abstract][Full Text] [Related]
30. Control of nausea and vomiting by Navoban (tropisetron) in 131 children receiving cytotoxic chemotherapy.
Benoit Y; Hulstaert F; Vermylen C; Sariban E; Hoyoux C; Uyttebroeck A; Otten J; Laureys G; De Kerpel I; Nortier D
Anticancer Drugs; 1995 Feb; 6 Suppl 1():9-14. PubMed ID: 7749170
[TBL] [Abstract][Full Text] [Related]
31. Prevention of emesis by tropisetron (Navoban) in children receiving cytotoxic therapy for solid malignancies.
Otten J; Hachimi-Idrissi S; Balduck N; Maurus R
Semin Oncol; 1994 Oct; 21(5 Suppl 9):17-9. PubMed ID: 9113122
[TBL] [Abstract][Full Text] [Related]
32. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience.
Sorbe B
Ann Oncol; 1993; 4 Suppl 3():39-42. PubMed ID: 8363999
[TBL] [Abstract][Full Text] [Related]
33. Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicin.
Nicolaides C; Giannakakis T; Skarlos D; Athanassiadis A; Fountzilas G; Damigos D; Pavlidis N
J Exp Clin Cancer Res; 1998 Mar; 17(1):71-5. PubMed ID: 9646236
[TBL] [Abstract][Full Text] [Related]
34. [The clinical effect of Tropisetron in the prevention of nausea and vomiting induced by anti-cancer drugs].
Wang J; Yang L; Cui C
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):251-3. PubMed ID: 11783100
[TBL] [Abstract][Full Text] [Related]
35. Current issues in the management of nausea and vomiting.
Gralla RJ
Ann Oncol; 1993; 4 Suppl 3():3-7. PubMed ID: 8363996
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and tolerability of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin.
Schmidt M; Sorbe B; Högberg T; Himmelmann A; Räisänen I; Stockmeyer M; de Bruijn KM
Ann Oncol; 1993; 4 Suppl 3():31-4. PubMed ID: 8363997
[TBL] [Abstract][Full Text] [Related]
37. Tropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting--the Nordic experience.
Sorbe B; Andersson H; Schmidt M; Söderberg M; Högberg T; Wernstedt L; Janson ET; Ehrnström B; Kjaer M; Havsteen H
Support Care Cancer; 1994 Nov; 2(6):393-9. PubMed ID: 7858934
[TBL] [Abstract][Full Text] [Related]
38. Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomiting.
Hulstaert F; Van Belle S; Bleiberg H; Canon JL; Dewitte M; Buyse M; De Keyser P; Westelinck KJ
J Clin Oncol; 1994 Nov; 12(11):2439-46. PubMed ID: 7964961
[TBL] [Abstract][Full Text] [Related]
39. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
J Clin Oncol; 1997 Jan; 15(1):124-30. PubMed ID: 8996133
[TBL] [Abstract][Full Text] [Related]
40. Tropisetron plus haloperidol to ameliorate nausea and vomiting associated with high-dose alkylating agent cancer chemotherapy.
Bregni M; Siena S; Di Nicola M; Bonadonna G; Gianni AM
Eur J Cancer; 1991; 27(5):561-5. PubMed ID: 1828962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]